Back to search

Article

Proteomic profiling of CSF reveals stage-specific changes in Amyotrophic lateral sclerosis patients

2026-04-16

Abstract excerpt

Amyotrophic lateral sclerosis (ALS) is a rapidly progressing neurodegenerative disease with a heterogeneous clinical presentation, complicating early diagnosis and therapeutic monitoring. To identify disease-specific biomarkers, we performed an unbiased cerebrospinal fluid (CSF) proteomic analysis in 87 ALS patients, 89 healthy controls, and 61 neurological controls using data-independent mass spectrometry. Across...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
7cdf2bf2-bfb4-548d-9612-46224b3facf6
DOI
10.64898/2026.04.13.26350753
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Proteomic profiling of CSF reveals stage-specific changes in Amyotrophic lateral sclerosis patientsDOI 10.64898/2026.04.13.26350753
Select a neighboring publication to make it the new centre.